Seeking Single Cells Secrets
The National Institutes of Health has awarded grants totaling $7.9 million in 2014 to 25 research teams who are unraveling the workings of single cells, as part of an effort to spur development of personalized treatments that target disease at the cellular level. The grants are supported by the NIH Common Fund’s Single Cell Analysis Program (SCAP).
“Cells are the most basic form of life; they make up every tissue and organ system in our bodies,” said James Anderson, director of NIH’s Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI). “Most cells are healthy, but this can change. They can become cancerous, get infected by viruses, undergo cycles and ageing. With these awards, we are making an investment that holds promise for widespread advances across medicine.”
This year’s SCAP grants fund applications submitted in response to requests for applications issued last December.
One group of projects is validating and refining already established technologies for studying the biological properties of single cells:
• Modeling how tissue properties of cells emerge during development
• Detecting genetic changes in live animals
• Manipulating cells with submicron precision
• Tracking fat metabolism using millisecond technology
• Detecting the tiniest genetic variation
• Discovering how cells renew themselves and differentiate as they develop
• Profiling gene expression in a cell’s nucleus to identify early protein signatures
• Optimizing “disease-in-a-dish” analysis
One group of grants is pioneering exceptionally innovative new technologies:
• A genetic imaging tool to label vast numbers of cell lineages
• Microsecond spectroscopy to repetitively assess a single cell in a living organism
• A high definition cell “printer” based on precise fluid mechanics, robotics and microscopy
• Optically guided technology to identify cell types that give rise to different tissues
• Light-induced cellular gene changes in a live vertebrate animal
• Gene expression sensors that report out changes among cells in living tissue
• Real-time, micro-level scans tracking a transplanted cell in a live mouse
• Spectrometry so sensitive that even subcellular components can be chemically analyzed
And one group of grants adds a single cell component to already active projects:
• How a key immune cell can be either an acute defender or a memory cell
• How a mouth bacterium can cause minor irritation or aggressive periodontal disease
• Tracking environmentally triggered changes in a gene in a formative human cell
• Characterizing how micro-level gene expression changes in a cancer cell suppress tumors
• How a gene regulator exerts effects on different classes of target genes
• Genetic mechanisms by which intestinal lining cells are regenerated
• Targeted genetic alteration of a key cellular process by which genes are switched off
• Characterizing the workings of immune cells that target leukemia
• Genetics of a disease-in-a-dish disease model derived from a type of heart cell.
For a detailed description of all funded SCAP grants, click here.
Related News
-
News Understanding the Benefits and Advances of Cleanroom Technology
In an industry where precision and sterility are crucial concerns, cleanrooms play a vital role in maintaining the integrity of pharmaceutical products like drugs, vaccines, and other medical products. So, what is a cleanroom?
-
News AbbVie secures GBP£1.2 billion deal for Gilgamesh’s psychedelic programme
AbbVie has penned a significant agreement to acquire the bretisilocin programme from Gilgamesh Pharmaceuticals for up to £1.2 billion, marking a bold step in the pharmaceutical giant's quest to develop treatments for psychiatric disorders. -
News Gates Foundation commits US$2.5 billion to women’s health research
The Bill & Melinda Gates Foundation has announced a substantial US$2.5 billion commitment to accelerate research and development focused exclusively on women's health through 2030.
-
News Mid-year review: notable FDA drug approvals of 2025
As we fly past the halfway point of 2025, the pharmaceutical landscape reliably continues to evolve with innovative therapies addressing critical medical needs. The FDA has already approved 17 groundbreaking medications this year, each representin... -
News US FDA announces new priority vouchers for accelerated review times
The US FDA announced a new priority program for drug developers – the Commissioner’s National Priority Voucher (CNPV) program aims to enhance the health interests of the US by allowing drug developers to redeem a voucher, shortening th... -
News Google-backed start-up raises US$600 million to support AI drug discovery and design
London-based Isomorphic Labs, an AI-driven drug design and development start-up backed by Google’s AI research lab DeepMind, has raised US$600 million in its first external funding round by Thrive Capital. The funding will provide further power t... -
News AstraZeneca to invest US$2.5 billion in Beijing R&D centre
Amid investigations of former AstraZeneca China head Leon Wang in 2024, AstraZeneca have outlined plans to establish its sixth global strategic R&D centre in China. Their aim is to further advance life sciences in China with major research and manufact... -
News Experimental drug for managing aortic valve stenosis shows promise
The new small molecule drug ataciguat is garnering attention for its potential to manage aortic valve stenosis, which may prevent the need for surgery and significantly improve patient experience.